Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization

B.A. Mooso, R.L. Vinall, C.G. Tepper, R.M. Savoy, J.P. Cheung, S. Singh, S. Siddiqui, Y. Wang, R.G. Bedolla, A. Martinez, M. Mudryj, H.-J. Kung, R.W. DeVere White, P.M. Ghosh

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

As prostate cancer (CaP) is regulated by androgen receptor (AR) activity, metastatic CaP is treated with androgen deprivation therapy (ADT). Despite initial response, patients on ADT eventually progress to castration-resistant CaP (CRPC), which is currently incurable. We previously showed that cleavage of the 280 kDa structural protein Filamin A (FlnA) to a 90 kDa fragment, and nuclear localization of the cleaved product, sensitized CRPC cells to ADT. Hence, treatment promoting FlnA nuclear localization would enhance androgen responsiveness. Here, we show that FlnA nuclear localization induced apoptosis in CRPC cells during ADT, identifying it as a treatment tool in advanced CaP. Significantly, the natural product genistein combined polysaccharide (GCP) had a similar effect. Investigation of the mechanism of GCP-induced apoptosis showed that GCP induced FlnA cleavage and nuclear localization and that apoptosis resulting from GCP treatment was mediated by FlnA nuclear localization. Two main components of GCP are genistein and daidzein: the ability of GCP to induce G2 arrest was due to genistein whereas sensitivity to ADT stemmed from daidzein; hence, both were needed to mediate GCP's effects. FlnA cleavage is regulated by its phosphorylation; we show that ADT enhanced FlnA phosphorylation, which prevented its cleavage, whereas GCP inhibited FlnA phosphorylation, thereby sensitizing CaP cells to ADT. In a mouse model of CaP recurrence, GCP, but not vehicle, impeded relapse following castration, indicating that GCP, when administered with ADT, interrupted the development of CRPC. These results demonstrate the efficacy of GCP in promoting FlnA nuclear localization and enhancing androgen responsiveness in CaP. © 2012 Society for Endocrinology.
Original languageEnglish
Pages (from-to)759-777
Number of pages19
JournalEndocrine-Related Cancer
Volume19
Issue number6
DOIs
Publication statusPublished - Dec 2012
Externally publishedYes

Keywords

  • daidzein
  • filamin A
  • genistein
  • polysaccharide
  • advanced cancer
  • androgen deprivation therapy
  • animal experiment
  • animal model
  • apoptosis
  • article
  • cancer recurrence
  • castration
  • cell cycle arrest
  • controlled study
  • human
  • human cell
  • male
  • mouse
  • nonhuman
  • prostate cancer
  • protein phosphorylation
  • tumor xenograft
  • Androgen Antagonists
  • Androgens
  • Anilides
  • Animals
  • Apoptosis
  • Castration
  • Cell Cycle Checkpoints
  • Cell Line, Tumor
  • Cell Nucleus
  • Filamins
  • Genistein
  • Male
  • Mice
  • Mice, Nude
  • Nitriles
  • Polysaccharides
  • Prostatic Neoplasms
  • Tosyl Compounds
  • Tumor Burden

Fingerprint Dive into the research topics of 'Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization'. Together they form a unique fingerprint.

  • Cite this

    Mooso, B. A., Vinall, R. L., Tepper, C. G., Savoy, R. M., Cheung, J. P., Singh, S., Siddiqui, S., Wang, Y., Bedolla, R. G., Martinez, A., Mudryj, M., Kung, H-J., DeVere White, R. W., & Ghosh, P. M. (2012). Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization. Endocrine-Related Cancer, 19(6), 759-777. https://doi.org/10.1530/ERC-12-0171